Moderna Says Trial Suggests Redesigned Vaccines Protect Against Variants
Researchers combined Modernas existing vaccine with one designed to attack the Beta variant, and found it provided a stronger defense against several variants.
Researchers combined Modernas existing vaccine with one designed to attack the Beta variant, and found it provided a stronger defense against several variants.